• Idiopathic and Hereditary Pancreatitis
  • Hepatitis B Surface Antigen (HBsAg), Qualitative or Quantitative
  • Alpha 1 Antitrypsin Genotyping/Phenotyping
  • Filaria Antibody, IgG4
  • Trazodone, Serum
  • B-cell Activating Factor Receptor (BAFF-R), Flow Cytometry
  • Human Immunodeficiency Virus (HIV) Antigen and Antibodies Combo, 4th Generation
  • Tangier disease (Familial alpha-lipoprotein deficiency)
  • BCR-ABL Translocation by RT-PCR, Quantitative, Blood
  • Neuroendocrine Neoplasms (Carcinoid Tumors)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

Turnaround Time
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.